110 related articles for article (PubMed ID: 19274060)
1. GNAS1 T393C polymorphism is associated with histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.
Alakus H; Warnecke-Eberz U; Bollschweiler E; Mönig SP; Vallböhmer D; Brabender J; Drebber U; Baldus SE; Riemann K; Siffert W; Hölscher AH; Metzger R
Pharmacogenomics J; 2009 Jun; 9(3):202-7. PubMed ID: 19274060
[TBL] [Abstract][Full Text] [Related]
2. Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy.
Alakus H; Bollschweiler E; Hölscher AH; Warnecke-Eberz U; Frazer KA; Harismendy O; Lowy AM; Mönig SP; Eberz PM; Maus M; Drebber U; Siffert W; Metzger R
Ann Surg Oncol; 2014 Dec; 21(13):4375-82. PubMed ID: 24986238
[TBL] [Abstract][Full Text] [Related]
3. GNAS1 T393C polymorphism and survival in patients with sporadic colorectal cancer.
Frey UH; Alakus H; Wohlschlaeger J; Schmitz KJ; Winde G; van Calker HG; Jöckel KH; Siffert W; Schmid KW
Clin Cancer Res; 2005 Jul; 11(14):5071-7. PubMed ID: 16033819
[TBL] [Abstract][Full Text] [Related]
4. The GNAS1 T393C polymorphism predicts survival in patients with clear cell renal cell carcinoma.
Frey UH; Lümmen G; Jäger T; Jöckel KH; Schmid KW; Rübben H; Müller N; Siffert W; Eisenhardt A
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):759-63. PubMed ID: 16467086
[TBL] [Abstract][Full Text] [Related]
5. Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.
Narumiya K; Metzger R; Bollschweiler E; Alakus H; Brabender J; Drebber U; Hölscher AH; Warnecke-Eberz U
Pharmacogenomics; 2011 Feb; 12(2):205-14. PubMed ID: 21332314
[TBL] [Abstract][Full Text] [Related]
6. The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer.
Vashist YK; Kutup A; Musici S; Yekebas EF; Mina S; Uzunoglu G; Zehler O; Koenig A; Cataldegirmen G; Bockhorn M; Effenberger K; Kalinin V; Pantel K; Izbicki JR
Cell Oncol (Dordr); 2011 Aug; 34(4):281-8. PubMed ID: 21340746
[TBL] [Abstract][Full Text] [Related]
7. The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.
Frey UH; Nückel H; Sellmann L; Siemer D; Küppers R; Dürig J; Dührsen U; Siffert W
Clin Cancer Res; 2006 Oct; 12(19):5686-92. PubMed ID: 17020971
[TBL] [Abstract][Full Text] [Related]
8. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
Xi H; Baldus SE; Warnecke-Eberz U; Brabender J; Neiss S; Metzger R; Ling FC; Dienes HP; Bollschweiler E; Moenig S; Mueller RP; Hoelscher AH; Schneider PM
Clin Cancer Res; 2005 Dec; 11(23):8341-7. PubMed ID: 16322294
[TBL] [Abstract][Full Text] [Related]
9. The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum.
Xie FJ; Zhao P; Kou JY; Hong W; Fu L; Hu L; Hong D; Su D; Gao Y; Zhang YP
Cancer Chemother Pharmacol; 2012 Jun; 69(6):1443-8. PubMed ID: 22371153
[TBL] [Abstract][Full Text] [Related]
10. The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer.
Frey UH; Eisenhardt A; Lümmen G; Rübben H; Jöckel KH; Schmid KW; Siffert W
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):871-7. PubMed ID: 15824158
[TBL] [Abstract][Full Text] [Related]
11. The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer.
Uzunoglu FG; Heumann A; Musici S; Kutup A; Koenig A; Roch N; Thomssen A; Dohrmann T; Tsui TY; Mann O; Izbicki JR; Vashist YK
Lung Cancer; 2013 Feb; 79(2):151-5. PubMed ID: 23201296
[TBL] [Abstract][Full Text] [Related]
12. The CC genotype of the GNAS T393C polymorphism is associated with obesity and insulin resistance in women with polycystic ovary syndrome.
Hahn S; Frey UH; Siffert W; Tan S; Mann K; Janssen OE
Eur J Endocrinol; 2006 Nov; 155(5):763-70. PubMed ID: 17062894
[TBL] [Abstract][Full Text] [Related]
13. Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.
Lehnerdt GF; Franz P; Zaqoul A; Schmitz KJ; Grehl S; Lang S; Schmid KW; Siffert W; Jahnke K; Frey UH
Clin Cancer Res; 2008 Mar; 14(6):1753-8. PubMed ID: 18347176
[TBL] [Abstract][Full Text] [Related]
14. GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma.
Frey UH; Fritz A; Rotterdam S; Schmid KW; Potthoff A; Altmeyer P; Siffert W; Brockmeyer NH
Eur J Med Res; 2010 Oct; 15(10):422-7. PubMed ID: 21156401
[TBL] [Abstract][Full Text] [Related]
15. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Prenzel KL; König A; Schneider PM; Schnickmann C; Baldus SE; Schröder W; Bollschweiler E; Dienes HP; Mueller RP; Izbicki JR; Hölscher AH
Ann Surg Oncol; 2007 Feb; 14(2):954-9. PubMed ID: 17103071
[TBL] [Abstract][Full Text] [Related]
16. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
Brabender J; Arbab D; Huan X; Vallböhmer D; Grimminger P; Ling F; Neiss S; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
Ann Surg Oncol; 2009 May; 16(5):1378-83. PubMed ID: 19224282
[TBL] [Abstract][Full Text] [Related]
17. GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinoma.
Schmitz KJ; Lang H; Frey UH; Sotiropoulos GC; Wohlschlaeger J; Reis H; Takeda A; Siffert W; Schmid KW; Baba HA
Neoplasia; 2007 Feb; 9(2):159-65. PubMed ID: 17356712
[TBL] [Abstract][Full Text] [Related]
18. The GNAS1 T393C polymorphism predicts survival in patients with advanced squamous cell carcinoma of the larynx.
Lehnerdt GF; Franz P; Winterhoff S; Bankfalvi A; Grehl S; Lang S; Schmid KW; Siffert W; Jahnke K; Frey UH
Laryngoscope; 2008 Dec; 118(12):2172-6. PubMed ID: 19029852
[TBL] [Abstract][Full Text] [Related]
19. Gender-dependent association of the GNAS1 T393C polymorphism with early aseptic loosening after total hip arthroplasty.
Bachmann HS; Hanenkamp S; Kornacki B; Frey UH; Bau M; Siffert W; Wedemeyer C
J Orthop Res; 2008 Dec; 26(12):1562-8. PubMed ID: 18634020
[TBL] [Abstract][Full Text] [Related]
20. Association of the GNAS1 T393C polymorphism with tumor stage and survival in gastric cancer.
Alakus H; Mönig SP; Warnecke-Eberz U; Alakus G; Winde G; Drebber U; Schmitz KJ; Schmid KW; Riemann K; Siffert W; Bollschweiler E; Hölscher AH; Metzger R
World J Gastroenterol; 2009 Dec; 15(48):6061-7. PubMed ID: 20027678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
